MODIFICATION
65 -- BARDA Broad Agency Announcement (BAA) for Advanced Research and Development of Personal Protective Equipment, Ventilators, and Diagnostics
- Notice Date
- 6/23/2011
- Notice Type
- Modification/Amendment
- NAICS
- 339112
— Surgical and Medical Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, Office of the Secretary, Acquisitions Management, Contracts, & Grants (AMCG), Office of the Assistant Secretary for Preparedness & Response (ASPR), Department of Health and Human Services, 330 Independence Ave. SW, G640, Washington, District of Columbia, 20201, United States
- ZIP Code
- 20201
- Solicitation Number
- 11-100-SOL-00021
- Archive Date
- 6/17/2011
- Point of Contact
- Dorothy McMillan, Phone: 202-260-8541, Tasha A. McMillian, Phone: 202-205-1502
- E-Mail Address
-
dorothy.mcmillan@hhs.gov, tasha.mcmillian@hhs.gov
(dorothy.mcmillan@hhs.gov, tasha.mcmillian@hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- UPDATE June 23, 2011: The BAA for this notice was posted on the Federal Business Opportuniities website on Monday, June 20, 2011. The BAA number is BAA-11-100-SOL-00021. A search using that number will take you directly to the BAA announcement. The points of contact for this requriement have also been updated. Please direct all inquiries to the Contracting Officer and/or Contract Specialist listed below. BARDA is the lead federal agency for the advanced development of medical countermeasures (MCM) to protect the United States against public health emergency threats, including chemical, biological, radiological and nuclear agents, emerging infectious diseases, and pandemic influenza. The 2009 H1N1 influenza pandemic exemplified the unpredictability and rapidity with which a novel influenza strain can impact the world's population. With a historic effort from both government and industry partners, vaccines were developed and available to the public six months after the initial outbreak. Despite high infection rates, the 2009 H1N1 virus was only mildly pathogenic, with relatively low rates of accompanying morbidity and mortality in the overall population. However, it is possible that future pandemics will feature morbidity and mortality rates comparable with historically more severe pandemics such as 1918 and 1957. The ever-present and ever-evolving threat of pandemic influenza presents a compelling need to optimize available medical countermeasures and develop entirely new modalities for prevention and treatment of influenza disease. This BAA will support advanced development activities to improve personal protective equipment, ventilators, clinical influenza test systems and diagnostic tools. The Pandemic and All Hazard Preparedness Act directs BARDA to promote (i) innovations in technologies that may assist MCM advanced research and development, (ii) research and development of tools, devices, and technologies, and (iii) research to promote strategic initiatives, such as rapid diagnostics, broad spectrum antimicrobials, and vaccine manufacturing technologies. The priorities of the BARDA Influenza Division are closely aligned with the National Strategy for Pandemic Influenza (Nov, 2005), the National Pandemic Influenza Implementation Plan (May, 2005), recommendations from the Public Health Emergency Medical Countermeasure Enterprise Review (Aug, 2010) and the President's Council of Advisors on Science and Technology report on influenza vaccines manufacturing (Aug, 2010). The HHS Public Health Emergency Medical Countermeasures Enterprise Review emphasizes the need to improve medical countermeasure technologies and move towards a "nimble, flexible capacity to produce MCMs rapidly in the face of any attack or threat". The purpose of this BAA is to solicit proposals that focus on one or more of the following solicited areas of interest. Development Areas of Interest: • Personal Protective Equipment and Full-Featured Continuous Ventilators for Influenza Infection & All-Hazards • Clinical Influenza Test Systems and Diagnostic Tools The Government intends to have a full & open competition for this requirement in the form of a BAA, which is anticipated to be issued on June 21, 2011. The Government expects to make one or more awards, subject to the availability of funds, over the period of one year. Point of Contact : Questions and comments regarding this announcement, referencing synopsis BAA BARDA 11-100-SOL-00021, may be submitted to FLU-BAA@hhs.gov.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/OOS/OASPHEP/11-100-SOL-00021/listing.html)
- Place of Performance
- Address: Department of Health & Human Services (DHHS), Office of the Assistant Secretary for Preparedness & Response (ASPR), Acquisitions Management, Contracts & Grants (AMCG), 330 Independence Ave., SW, Room G-640, Washington, D.C. 20201, United States
- Zip Code: 20201
- Zip Code: 20201
- Record
- SN02481184-W 20110625/110623235714-09d28be9499639cc07d61de8d0064633 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |